These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31557756)

  • 1. Impressive Response to Capecitabine in a Patient with Obstructive Jaundice due to Metastatic Triple-Negative Breast Cancer.
    Sattwika PD; Oktariani S; Leo B; Sagiran ; Iqbal M; Choridah L; Bayupurnama P; Kurnianda J; Hutajulu SH
    Oncol Res Treat; 2019; 42(11):607-611. PubMed ID: 31557756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.
    Ferrero JM; Hardy-Bessard AC; Capitain O; Lortholary A; Salles B; Follana P; Herve R; Deblock M; Dauba J; Atlassi M; Largillier R
    Cancer; 2016 Oct; 122(20):3119-3126. PubMed ID: 27412268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful resection of metachronous para-aortic, Virchow lymph node and liver metastatic recurrence of rectal cancer.
    Takeshita N; Fukunaga T; Kimura M; Sugamoto Y; Tasaki K; Hoshino I; Ota T; Maruyama T; Tamachi T; Hosokawa T; Asai Y; Matsubara H
    World J Gastroenterol; 2015 Nov; 21(44):12722-8. PubMed ID: 26640350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
    Masuda N; Lee SJ; Ohtani S; Im YH; Lee ES; Yokota I; Kuroi K; Im SA; Park BW; Kim SB; Yanagita Y; Ohno S; Takao S; Aogi K; Iwata H; Jeong J; Kim A; Park KH; Sasano H; Ohashi Y; Toi M
    N Engl J Med; 2017 Jun; 376(22):2147-2159. PubMed ID: 28564564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Fulvestrant with Low-Dose Capecitabine is Effective and Tolerable in Woman with Metastatic Breast Cancer.
    Nakai M; Takei H; Yanagihara K; Yamashita K; Uchida E
    J Nippon Med Sch; 2016; 83(2):81-6. PubMed ID: 27180793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine.
    O'Shaughnessy J; Koeppen H; Xiao Y; Lackner MR; Paul D; Stokoe C; Pippen J; Krekow L; Holmes FA; Vukelja S; Lindquist D; Sedlacek S; Rivera R; Brooks R; McIntyre K; Brownstein C; Hoersch S; Blum JL; Jones S
    Clin Cancer Res; 2015 Oct; 21(19):4305-11. PubMed ID: 26041745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elderly woman with triple-negative metastatic breast cancer successfully treated with metronomic capecitabine.
    De Iuliis F; Salerno G; Taglieri L; Vicinanza R; Lanza R; Scarpa S
    Anticancer Res; 2014 Aug; 34(8):4287-91. PubMed ID: 25075060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients.
    Torres A; Ramdial JL; Aguirre LE; Mahtani R; Vogel CL
    Breast Cancer Res Treat; 2019 Jul; 176(2):253-260. PubMed ID: 30900138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer.
    Alagizy HA; Shehata MA; Hashem TA; Abdelaziz KK; Swiha MM
    Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):22-7. PubMed ID: 25528114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irinotecan and capecitabine combination chemotherapy in a patient with triple-negative breast cancer relapsed after adjuvant chemotherapy with anthracycline and taxane.
    Lee A; Go SI; Lee WS; Lee US; Kim MJ; Kang MH; Lee GW; Kim HG; Kang JH; Jeon KN; Cho JM; Lee JH
    Tumori; 2015 Mar; 101(1):e9-e12. PubMed ID: 25702650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial.
    Coleman R; Brown J; Rathbone E; Flanagan L; Reid A; Kendall J; Howell S; Twelves C; Palmieri C; Anand A; MacPherson I; Brown S
    Trials; 2020 Jan; 21(1):89. PubMed ID: 31941523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modified FOLFOX6 treatment for obstructive jaundice caused by hepatic lymph-node metastasis from liver metastases of rectal cancer--a case report].
    Ishiguro T; Kitaoka T; Sakimoto T; Miyazaki T; Yokoyama M; Ishibashi K; Matsuki M; Inoue N; Sano M; Ishida H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2138-40. PubMed ID: 19106549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of elderly metastatic breast cancer with a complete response to treatment with capecitabine and cyclophosphamide].
    Iida S; Furukawa K; Yokoyama T; Yanagihara K; Iwasaki R; Noguchi T; Tsuchiya S; Sugisaki Y; Naito Z; Tajiri T
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1697-700. PubMed ID: 17940394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function.
    Schüll B; Scheithauer W; Kornek GV
    Onkologie; 2003 Dec; 26(6):578-80. PubMed ID: 14709934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of regimens of capecitabine-based chemotherapy in the treatment of advanced breast cancer].
    Huang HY; Jiang ZF; Wang T; Zhang SH; Bian L; Cao Y; Wu SK; Song ST
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):850-3. PubMed ID: 22335952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast Cancer with Multiple Liver Metastases Successfully Treated with Capecitabine Monotherapy after Failure of Combination Therapy Comprising Bevacizumab and Paclitaxel].
    Ooe A; Suganuma Y
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):349-51. PubMed ID: 27067853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancer.
    Babacan T; Efe O; Hasirci AS; Demirci F; Buyukhatipoglu H; Balakan O; Sarici F; Kertmen N; Esin E; Akin S; Ates O; Aksoy S; Sever AR; Altundag K
    Tumori; 2015; 101(4):418-23. PubMed ID: 25953439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant capecitabine for HER2-negative breast cancer.
    Burki TK
    Lancet Oncol; 2017 Jul; 18(7):e375. PubMed ID: 28602775
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
    Harbeck N; Saupe S; Jäger E; Schmidt M; Kreienberg R; Müller L; Otremba BJ; Waldenmaier D; Dorn J; Warm M; Scholz M; Untch M; de Wit M; Barinoff J; Lück HJ; Harter P; Augustin D; Harnett P; Beckmann MW; Al-Batran SE;
    Breast Cancer Res Treat; 2017 Jan; 161(1):63-72. PubMed ID: 27798749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.